Staged 30-40% trim into $610-$622 resistance; structural floor precludes full exit, confirmed deterioration precludes Hold
Underweight rating reflects confirmed fundamental deterioration (1200 bps operating margin compression in single quarter, CapEx consuming 94.5% of OCF, 81% FCF collapse YoY, three-consecutive-quarter buyback pause) that has moved beyond where neutral weight is defensible. Structural floor ($90.3B liquidity, 30% ROE, 81% gross margins, $31.86B quarterly OCF) precludes full exit. Three binding prior lessons argue for staged trim into resistance rather than pre-committed reduction: (1) neutral weight is implicitly short volatility in confirmed-quality-broken-trend setups, (2) light 15-20% trim captures downside without abandoning structural floor, (3) magnitude discipline avoids bleeding alpha in wrong direction. Staged execution honors momentum (MACD histogram +3.86, RSI 55.18, higher-low sequence) at 50 SMA decision point. Upgrade to Hold/Overweight requires Q3 earnings confirming FCF stabilization with moderated 2027 capex guidance, sustained close above $640 with volume confirming 200 SMA reclaim, buyback resumption, or CapEx/OCF ratio moving materially below 94.5%.
| Position | Action |
|---|---|
| Current position | Reduce 30-40% via staged execution |
| Target residual allocation | ~2.0% of NAV |
| Hard cap | 2.25% of NAV (tightened from 2.5% given beta 1.243 and ATR $20.25) |
| Hard close below $571 on volume | Remove remaining tactical exposure |
| Daily close below $525 on heavy volume | Catastrophic break - full exit |
META at $592 represents a tactical long opportunity with 28% YoY revenue growth, fortress balance sheet ($90.3B cash, 2.23 current ratio), and compelling valuation (forward P/E 16.96, PEG 0.77) that will re-rate as AI infrastructure investments (Construction in Progress $80.3B) begin generating returns, making the current FCF compression a temporary investment-mode artifact rather than structural deterioration.
| Indicator | Value | Signal |
|---|---|---|
| close | $592.85 | neutral |
| volume | 16.4M | bullish |
| 10_ema | $575.46 | bullish |
| 50_sma | $592.95 | neutral |
| 200_sma | $621.51 | bearish |
| rsi | 55.18 | bullish |
| macd_line | -4.22 | neutral |
| macd_signal | -8.08 | bullish |
| macd_histogram | +3.86 | bullish |
| boll_middle | $574.61 | bullish |
| boll_upper | $610.46 | neutral |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: Price tags $618-$622 zone (200 SMA at $621.51, upper Bollinger at $610.46)
Then: Complete remaining 10-20% of trim
AI capex is productive capital generating revenue via LLaMA/Muse Spark, ad targeting, and enterprise WhatsApp/IG/FB
↩ rebuts: “Piper Sandler note about sliding AI ROIC assumes AI capex is sunk cost”
EV: +4.5% to first target $610; +4.8% to second target $621 · concedes: Short-term FCF compression due to CapEx cycle ($1.75B in Q2 2026); $10B Q3 settlement charge will impact books; Buybacks paused ($0 in Q2 2026); 200 SMA overhead resistance at $621.51 (4.8% above); Net debt increase from $16.8B to $68.2B; Path to $750+ prior highs requires reclaiming $621 first
Meta is in an aggressive capital deployment cycle that is destroying FCF, compressing margins, and removing equity support mechanisms, making the current valuation expensive relative to deteriorating earnings power.
EV: $475-510 (12-month price target) · concedes: Revenue is growing 28% year-over-year, which is impressive at scale; The company has $90.3B in cash, providing near-term balance sheet flexibility; Polymarket assigns 96% probability to Meta shipping a next-gen AI model
→ vs conservative: Cash position of $90.3B is not a defensive moat but fuel for a $145B annual capex bet with deteriorating ROIC; levering up net debt 305% YoY while ROIC slides is the opposite of safety
→ vs conservative: Forward P/E of 16.96 anchored on earnings that assume AI monetization hits, but Polymarket implies only 26-40% probability; a 17x multiple on a questioned numerator is expensive relative to risk-adjusted outcome
→ vs conservative: 28% revenue growth while operating income fell 8% and margins contracted 1,200 bps is not a growth story; R&D up 67% YoY and capex-to-OCF approaching 100% transforms software platform into utility with uncertain payoff
→ vs neutral: Waiting for Q3 earnings confirmation is too late; FCF trajectory will be evident by then, stock will have broken $571, and trader will be selling into falling knife instead of into resistance ceiling available now
→ vs neutral: Technical setup at 50 SMA with 200 SMA rejection overhead and upper Bollinger Band at $610.46 is the precise level where supply overwhelms demand; VWMA at $567.16 signals short-term exhausted buyers to sell into
→ vs neutral: The trim is already active risk management, not abandonment; neutral's 'wait and hope' approach surrenders the asymmetric opportunity of selling into resistance with ATR-facilitated quick moves to $621
| boll_lower | $538.76 | neutral |
| atr | $20.25 | neutral |
| vwma | $567.16 | bullish |
Support: 575.46 · 571.1 · 560 · 542.87 · 538.76 | Resistance: 610.46 · 621.51 · 634
META is at a critical inflection point with short-term momentum bullish (higher lows since August bottom, positive MACD histogram, RSI neutral-leaning at 55.18 with room to extend) but medium- and long-term trends still broken until the 200-day SMA at $621.51 is reclaimed. Key resistance sits at $610.46 (upper Bollinger Band) and $621.51 (200 SMA), while critical support spans $575.46 (10 EMA), $571.10 (consolidation low), and the lower Bollinger Band at $538.76. The recommended bias is cautiously constructive for tactical longs with tight stops at $571.10, given the elevated ATR of $20.25 and counter-trend nature of the trade.
Market Cap
$1.51 trillion
P/E (TTM)
22.33
Forward P/E
16.96
PEG Ratio
0.77
Price/Book
5.78
EPS (TTM)
$26.55
Forward EPS
$34.96
Dividend Yield
0.36%
Beta
1.243
Revenue (TTM)
$228.25B
Revenue YoY (Q2 2026)
+28%
Revenue Q2 2026
$60.80B
Revenue Q2 2025
$47.52B
Revenue 2025
$201.0B
Revenue 2024
$164.5B
Revenue CAGR 2022-2025
~20%
Gross Margin
~81.7%
Operating Margin
34.83%
Net Margin
29.83%
Operating Margin Q2 2026
30.9%
Operating Margin Q2 2025
43.0%
Operating Margin YoY Change
~-1,200 bps
Operating Income YoY (Q2 2026)
-8%
Operating Income Q2 2026
$18.78B
Operating Income Q2 2025
$20.44B
Operating Income 2025
$83.3B
Net Income YoY (Q2 2026)
-14%
Net Income Q2 2026
$15.85B
Net Income Q3 2025
$2.71B
Net Income 2025
$60.5B
Net Income 2024
$62.4B
Net Income 2023
$39.1B
Net Income 2022
$23.2B
Diluted EPS 2025
$23.49
Diluted EPS 2024
$23.86
Diluted EPS 2023
$14.87
Diluted EPS 2022
$8.59
ROE
29.85%
ROA
14.59%
R&D YoY (Q2 2026)
+67%
R&D Q2 2026
$21.66B
R&D Q2 2025
$12.94B
Total Assets
$450.0B
Total Assets Q2 2025
$294.7B
Total Debt
$112.3B
Total Debt Q2 2025
$49.6B
Long-Term Debt
$83.7B
Long-Term Debt Q2 2025
$28.8B
Net Debt
$68.2B
Net Debt Q2 2025
$16.8B
Cash & ST Investments
$90.3B
Cash & ST Investments Q2 2025
$47.1B
Stockholders' Equity
$261.2B
Stockholders' Equity Q2 2025
$195.1B
Net PPE
$249.7B
Net PPE Q2 2025
$162.7B
Construction in Progress
$80.3B
Construction in Progress Q2 2025
$35.9B
Goodwill
$23.4B
Goodwill Q2 2025
$20.7B
Debt/Equity
0.43
Current Ratio
2.23
OCF Q2 2026
$31.86B
OCF Q2 2025
$25.56B
OCF 2025
$115.8B
OCF 2024
$91.3B
OCF 2023
$71.1B
OCF 2022
$50.5B
CapEx Q2 2026
$30.12B
CapEx Q2 2025
$16.54B
CapEx 2025
$69.7B
CapEx 2024
$37.3B
CapEx 2023
$27.0B
CapEx 2022
$31.2B
FCF Q2 2026
$1.75B
FCF Q2 2025
$9.02B
FCF 2025
$46.1B
FCF 2024
$54.1B
FCF 2023
$44.1B
FCF 2022
$19.3B
Dividends Paid Q2 2026
$1.35B
Dividends 2025
$5.3B
Dividends 2024
$5.1B
Buybacks Q2 2026
$0
Buybacks Q2 2025
$10.17B
Buybacks 2025
$26.2B
Buybacks 2024
$30.1B
Buybacks 2023
$19.8B
Buybacks 2022
$28.0B
Long-Term Debt Issued 2025
$29.9B
52-Week High
$790.80
52-Week Low
$520.26
50-Day MA
$592.34
200-Day MA
$622.30
Implied Current Price
~$592
Strengths
Concerns
Meta reported strong Q2 2026 revenue of $60.80B (+28% YoY) but faces severe margin compression as operating margin fell to 30.9% (-1,200 bps YoY) due to a 67% surge in R&D spending to $21.66B, while free cash flow collapsed to just $1.75B as CapEx reached $30.12B (50% of revenue); the balance sheet has shifted to an aggressive leveraged model with total debt up 127% to $112.3B, $80.3B in construction in progress (AI data centers), and buybacks completely paused, though the forward valuation remains compelling at P/E 16.96 with PEG 0.77 and the company maintains $90.3B in cash and strong quarterly OCF of $31.86B.
Macro: Macro backdrop is mixed: 89% probability of no Fed cuts in 2026 with 0% chance of 6+ cuts, elevated discount rates headwind for long-duration assets. Recession odds at 8% (US/UK) and 6% (Japan) are benign and supportive of ad revenue. Rising Treasury yields driven by U.S. debt issuance and AI-related borrowing create a higher cost of capital for Meta's $145B capex program, but also signal economic resilience. No FRED macro series available — commentary anchored to Polymarket-implied probabilities and contemporaneous news.